kspaziani

DenisCOVIDinfoguy, 25 days ago to auscovid19

Novavax Prepared to Deliver Protein-based Non-mRNA JN.1 COVID-19 Vaccine in Line with WHO Recommendation this Fall.

"Our most recent nonclinical data have demonstrated that our JN.1 vaccine candidate induces neutralization responses to JN.1, JN.4, JN.1.11.1, JN.1.7, JN.1.13.1 and JN.1.16 strains. Our JN.1 vaccine candidate also produces polyfunctional cellular CD4+ T cell responses to a range of omicron strains including JN.1 and JN.1.11. These responses indicate once again that our vaccine technology can induce broadly neutralizing responses against multiple variant strains, including circulating forward drift variants."

#Novavax #COVIDvaccine #JN1 @auscovid19

Source: https://ir.novavax.com/press-releases/Novavax-Prepared-to-Deliver-Protein-based-Non-mRNA-JN-1-COVID-19-Vaccine-in-Line-with-WHO-Recommendation-this-Fall